Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tarek A. Ghonemy"'
Publikováno v:
Alexandria Journal of Medicine, Vol 53, Iss 3, Pp 221-225 (2017)
Background: Chronic kidney disease is independently associated with cardiovascular disease (CVD) events in high-risk populations according to several studies. However, findings from community-based population studies are insufficient. We studied the
Externí odkaz:
https://doaj.org/article/d3312af3859b411c884cee0a905e9bd0
Publikováno v:
Alexandria Journal of Medicine, Vol 52, Iss 4, Pp 337-342 (2016)
Background: Pain is one of the most common complaints in clinical practice because it is a symptom for a myriad of physical and mental problems. The high prevalence of pain in the chronic kidney disease (CKD) population is particularly concerning bec
Externí odkaz:
https://doaj.org/article/a31a5d2c3ae14cedbc2e395f3aaf1007
Publikováno v:
Alexandria Journal of Medicine, Vol 52, Iss 1, Pp 67-71 (2016)
Background: Morbidity related to vascular access is the leading cause of hospitalization for chronic hemodialysis patients and is associated with high cost. Since data on vascular access complications are scarce, this study was designed to focus on v
Externí odkaz:
https://doaj.org/article/931042db10cb47339acdd73c455c0cd2
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 28, Iss 2, Pp 60-65 (2016)
Background Acute kidney injury (AKI) has consistently been associated with adverse clinical outcome after acute myocardial infarction (MI). In addition, AKI is well-known as a potent predictor of the clinical course in heart failure patients. The aim
Externí odkaz:
https://doaj.org/article/4d26a3a35a944480954d59e239462136
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 27, Iss 1, Pp 111-117 (2016)
End-stage renal disease (ESRD) is increasing worldwide. Renal replacement therapy and kidney transplantation are increasing the burden on health systems. Various risk factors can lead to this disease. In this work, we tried to study the epidemiology
Externí odkaz:
https://doaj.org/article/4300528abf5a4c29bb3d1fbacc91de09
Autor:
Ibrahim M. Salem, Abdallah M. Nawara, Mohamed M. Awadalla, Tarek A. Ghonemy, Mohamed A. Zanaty, Maher B. Borai, Mohamed I. Salem, Niveen S. Sakla
Background Cardiovascular disease is considered a common cause of morbidity and mortality in patients with end-stage renal disease on hemodialysis. Elevated levels of glycated hemoglobin (HbA1c) are associated with CVD in diabetic patients. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b4f085af9dabe0b3a61a2b3c1c54dba
https://doi.org/10.21203/rs.3.rs-2184530/v1
https://doi.org/10.21203/rs.3.rs-2184530/v1
Autor:
Tarek A Ghonemy, Ghada M Amro
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 3, Pp 582-588 (2014)
Acute kidney injury (AKI) is a common and serious condition that frequently occurs after cardiopulmonary bypass and other cardiac surgeries. The objective of this work is to evaluate the utility of new markers for kidney damage, plasma neutrophil gel
Externí odkaz:
https://doaj.org/article/c020098ca65546539a9353acbd0740e3
Autor:
Tarek A Ghonemy
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 23, Iss 1, Pp 129-132 (2012)
Externí odkaz:
https://doaj.org/article/340658e8423b4681ae6d491a69031f84
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 23, Iss 4, Pp 736-742 (2012)
Adiponectin is a novel collagen-like protein synthesized by white adipose tissue. Its levels are decreased in obesity, type-2 diabetes and insulin-resistant states, and are increased in chronic renal failure. It has anti-inflammatory and anti-atherog
Externí odkaz:
https://doaj.org/article/1a3ede2aeb3c4354bd23b59bbf8723bc
Autor:
Amir M Elokely, Esam Elden Lotfy, Sayed Elnahal, Amal F. Gharib, Tarek A Ghonemy, Hala M. Allam
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 28, Iss 2, Pp 60-65 (2016)
Background Acute kidney injury (AKI) has consistently been associated with adverse clinical outcome after acute myocardial infarction (MI). In addition, AKI is well-known as a potent predictor of the clinical course in heart failure patients. The aim